Form 8-K - Current report:
SEC Accession No. 0001171843-25-003868
Filing Date
2025-06-12
Accepted
2025-06-12 16:45:29
Documents
12
Period of Report
2025-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_061225.htm   iXBRL 8-K 28058
  Complete submission text file 0001171843-25-003868.txt   195184

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cmpx-20250611.xsd EX-101.SCH 3029
3 XBRL LABEL FILE cmpx-20250611_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE cmpx-20250611_pre.xml EX-101.PRE 22368
14 EXTRACTED XBRL INSTANCE DOCUMENT f8k_061225_htm.xml XML 3798
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39696 | Film No.: 251043502
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)